Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04429906
Other study ID # 2020114-0604
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date May 29, 2020
Est. completion date June 30, 2020

Study information

Verified date June 2020
Source Peking University First Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

This is a cross-sectional diagnostic study. In this study, wrist oxygen saturation (SwO2) will be measured by Huami smart wearable device, SpO2 of pulse oxygen saturation monitor with medical device registration certificate and SaO2 of arterial blood gas analysis will be used as reference values. A total of 180 group data will be measured in 30~50 patients with SaO2/ SpO2 between 80%∽100%. The investigators aim to evaluate the accuracy of blood oxygen saturation detection function of huami smart wearable device.


Description:

This is a cross-sectional diagnostic study. 30~50 inpatient aged 18~85y with SaO2/ SpO2 between 80%∽100% will be recruited from the Department of Respiratory and Critical Care of Peking University First Hospital. 180 group data ( 37 of SaO2/ SpO2 between 80%∽90%, 143 of SaO2/ SpO2 between 90%∽100%) will be measured, with an average of 4-6 groups per patient. Some clinical information such as demographic data, laboratory tests, comorbidity, smoking habit and will be collected. Patients have their pulse oximetry measured multiple times using a pulse oximeter/tabletop electrocardiograph with a medical device registration certificate, and arterial blood gas analysis will be performed if required. While monitoring the pulse oximetry, a Huami smart wearable device is worn on the ipsilateral wrist to determine blood oxygen saturation. Primary outcome is the wearable device oximetry accuracy Arms (root mean square value of the SwO2-RefSpO2 difference) using a medical device registration certificate pulse oximetry monitor/tabletop ECG monitor as a reference..

The study protocol has been approved by the Peking University First Hospital Institutional Review Board (IRB) (2020-114). Any protocol modifications will be submitted for the IRB review and approval.


Recruitment information / eligibility

Status Recruiting
Enrollment 30
Est. completion date June 30, 2020
Est. primary completion date June 30, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years to 85 Years
Eligibility Inclusion Criteria:

1. Inpatients in the Department of Respiratory and Critical Care at Peking University First Hospital

2. Oxygen intake or no oxygen intake when enrolled: 80%=SaO2/SpO2=100%

3. Age between 18 and 85 years, either gender

4. COHb<3%, MetHb<2%;

5. Sign an informed consent or sign an informed consent by a legally authorized representative;

6. Be willing and able to follow the research program.

Exclusion Criteria:

1. current smokers or those exposed to high levels of carbon monoxide.

2. critically ill patients who are in a state of shock, resulting in peripheral circulation disorders.

3. Patients with hypothermia below 35°C.

4. Patients with bilateral wrist and hand oedema, soft tissue damage to the wrist, skin incomplete and unable to wear a watch/ bracelet.

5. Vascular blood supply abnormalities of both upper limbs (occlusion, thrombosis, post-trauma, etc.), which affects the test results

6. Patients with bilateral upper extremity pigmentation affecting the test results;

7. Patients with limb mobility impairment due to severe cerebrovascular disease sequelae.

8. Patients with severe mental system disease that makes it impossible to cooperate with the researchers.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Huami smart wearable device
Wear the pulse-oxygen monitoring finger set of the medical monitor while wearing the Huami Smart Wearable device on the ipsilateral wrist according to the instructions for use. The medical monitor displays a steady pulse oximetry level for at least 30 seconds, starts the first measurement, slides the main dial page of the wearable device to the "Oxygen Saturation" measurement interface, clicks the measurement button to start the single measurement of blood oxygen saturation. Record the pulse oximetry and pulse rate values measured at the same time by the medical monitor and the Huami Smart Wearable Pulse Oximetry Device, respectively. After an interval of 30 seconds, repeat the above steps to start the second measurement and record the measured value. After an interval of 30 seconds, repeat the above steps to start the third measurement and record the measured value. The average of three measurements was taken as data for the test group.

Locations

Country Name City State
China Peking University First Hospital Beijing Beijing

Sponsors (2)

Lead Sponsor Collaborator
Peking University First Hospital Anhui Huami Information Technology Co., Ltd.

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Wearable device oximetry accuracy Arms Record the pulse oximetry and pulse rate values measured at the same time by the medical monitor and the Huami Smart Wearable Pulse Oximetry Device, respectively. After an interval of 30 seconds, repeat the above steps to start the second measurement and record the measured value. After an interval of 30 seconds, repeat the above steps to start the third measurement and record the measured value. The average of three measurements was taken as data for the test group.
Pulse oximetry monitor/desktop ECG monitor with a medical device registration certificate was selected as reference device A. The mean value of qualified pulse oximetry measured by pulse oximetry monitor/desktop ECG monitor was used as control group A measurement.
Wearable device oximetry accuracy Arms (root mean square value of the SwO2-RefSpO2 difference) using a medical device registration certificate pulse oximetry monitor/tabletop ECG monitor as a reference.
30mins
Secondary Wearable device blood oxygen saturation accuracy Arms Record the pulse oximetry and pulse rate values measured by the Huami Smart Wearable Pulse Oximetry Device. After an interval of 30 seconds, repeat the above steps to start the second measurement and record the measured value. After an interval of 30 seconds, repeat the above steps to start the third measurement and record the measured value. The average of three measurements was taken as data for the test group.A carbon monoxide blood gas analyzer (CO-oximeter) was selected as reference device B. Arterial blood was sampled and arterial oxygen saturation (SaO2) was obtained from the blood gas analyzer as a control group B measurement.Wearable device blood oxygen saturation accuracy Arms (expressed as root mean square value of the SwO2-SaO2 difference) using a carbon monoxide - blood gas analyzer (CO-oximeter) as reference. 30mins
Secondary Accuracy of blood oxygen saturation of wearable devices when SpO2/SaO2 is at 90%-100%. When SpO2/SaO2 is at 90%-100%,wearable device oximetry accuracy Arms (root mean square value of the SwO2-RefSpO2 difference) using a medical device registration certificate pulse oximetry monitor/tabletop ECG monitor as a reference;wearable device blood oxygen saturation accuracy Arms (expressed as root mean square value of the SwO2-SaO2 difference) using a carbon monoxide - blood gas analyzer (CO-oximeter) as reference. 30mins
Secondary Accuracy of blood oxygen saturation of wearable devices when SpO2/SaO2 is at 80%-89%. when SpO2/SaO2 is at 80%-89%,wearable device oximetry accuracy Arms (root mean square value of the SwO2-RefSpO2 difference) using a medical device registration certificate pulse oximetry monitor/tabletop ECG monitor as a reference;wearable device blood oxygen saturation accuracy Arms (expressed as root mean square value of the SwO2-SaO2 difference) using a carbon monoxide - blood gas analyzer (CO-oximeter) as reference. 30mins
Secondary Correlation analysis of parameters that have an impact on the accuracy of blood oxygen saturation of wearable devices. When the test result is negative, evaluate the parameters that have an impact on the accuracy of blood oxygen saturation of wearable devices. 30mins
Secondary The variability of blood oxygen saturation of wearable devices tested three times. Record the pulse oximetry and pulse rate values measured at the same time by the medical monitor and the Huami Smart Wearable Pulse Oximetry Device, respectively. After an interval of 30 seconds, repeat the above steps to start the second measurement and record the measured value. After an interval of 30 seconds, repeat the above steps to start the third measurement and record the measured value. Evaluate the variability of blood oxygen saturation of wearable devices tested three times. 30mins
See also
  Status Clinical Trial Phase
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT05995613 - Evaluation of MABOS for Improved Pulse Oximeter Accuracy in Patients of Color
Terminated NCT05030012 - Maintaining Optimal HVNI Delivery Using Automatic Titration of Oxygen in Preterm Infants N/A
Recruiting NCT06101641 - Effect of Shellac Nail Polish Application on Pulse Oximetry Measurements in Healthy Individuals N/A
Terminated NCT03967587 - Evaluation of Intravascular Monitoring of Partial PRessure of Oxygen for Neonatal intensiVE Care Patients N/A
Completed NCT03683316 - Work of Breathing and Kangaroo Mother Care
Completed NCT05784103 - Comparison of Tissue Oxygenation Measurement Using Multimodal Devices N/A
Recruiting NCT03873298 - Inhaled NO in IPF and COPD During 6 Minute Walk Test Phase 2
Completed NCT03439202 - Low Intensity Exercise in Different Normobaric/Hypobaric Normoxic/Hypoxic Conditions. N/A
Not yet recruiting NCT06283914 - Imputation of Arterial Oxygen Partial Pressures Using Pulse Oximetry
Recruiting NCT05022264 - Remote Investigation and Assessment of Vital Signs
Not yet recruiting NCT05886153 - Verification Protocol for the Cloud DX Vitaliti Continuous Vital Signs Monitor (VERDICT-2) N/A
Completed NCT02834845 - Comparison of Volatile Anesthetics on Cerebral Oxygenation During Controlled Hypotension Phase 4
Suspended NCT04252547 - Effect of Kangaroo Care on Test Weighing N/A
Completed NCT04346498 - Can Kangarooing Small Babies on the Back of a Mother Keep Them Warm and Stable N/A
Completed NCT02127333 - Role of Oxygen for Vascular Dysfunction N/A
Not yet recruiting NCT05451875 - Comparison of Continuous Non-invasive All Vital Signs Monitoring Devices With Invasive Gold Standard for Children
Completed NCT05683210 - Comparison of The Effects of Initial Oral Feeding by Cup and Bottle-Feeding of Preterm Infants N/A
Completed NCT02017691 - Cerebral Oxygenation to Guide Supplemental Oxygen Phase 1/Phase 2
Completed NCT05709262 - Comparison of Different Walk and Performance Test in Detecting Silent Hypoxia